Total Payments
$15,718
2024 Payments
$1,306
Companies
43
Transactions
546
Medicare Patients
8,027
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$10,353 (65.9%)
Research$5,008 (31.9%)
Other$213.96 (1.4%)
Education$116.78 (0.7%)
Gifts$27.28 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,353 | 539 | 65.9% |
| Unspecified | $5,008 | 1 | 31.9% |
| Entertainment | $213.96 | 1 | 1.4% |
| Education | $116.78 | 3 | 0.7% |
| Gift | $27.28 | 2 | 0.2% |
Payments by Type
General
$10,711
545 transactions
Research
$5,008
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch Health US, LLC | $5,008 | 1 | $0 (2022) |
| ABBVIE INC. | $2,507 | 123 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,283 | 80 | $0 (2024) |
| Janssen Biotech, Inc. | $1,249 | 76 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $766.96 | 46 | $0 (2024) |
| Romark Laboratories, LC | $517.34 | 18 | $0 (2020) |
| Ironwood Pharmaceuticals, Inc | $507.06 | 40 | $0 (2023) |
| Celgene Corporation | $467.71 | 30 | $0 (2024) |
| PFIZER INC. | $340.53 | 9 | $0 (2024) |
| GENZYME CORPORATION | $250.97 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,306 | 59 | ABBVIE INC. ($389.03) |
| 2023 | $1,538 | 83 | AbbVie Inc. ($615.43) |
| 2022 | $7,181 | 120 | Bausch Health US, LLC ($5,008) |
| 2021 | $1,564 | 83 | Janssen Biotech, Inc. ($561.57) |
| 2020 | $761.47 | 45 | IRONWOOD PHARMACEUTICALS, INC ($159.89) |
| 2019 | $882.77 | 48 | AbbVie, Inc. ($200.10) |
| 2018 | $1,013 | 51 | AbbVie, Inc. ($219.41) |
| 2017 | $1,470 | 57 | Romark Laboratories, LC ($373.47) |
All Payment Transactions
546 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/19/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.48 | General |
| 12/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $129.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/19/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $123.59 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.76 | General |
| 10/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/30/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/23/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $3.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/19/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Gastroenterology | ||||||
| 09/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 08/22/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/07/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Immunology | ||||||
| 08/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Gastroenterology | ||||||
| 07/29/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: ENDOCRINOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis | Bausch Health US, LLC | $5,008 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,946 | 14,427 | $793,640 | $306,994 |
| 2022 | 26 | 1,838 | 15,449 | $860,606 | $311,165 |
| 2021 | 28 | 2,094 | 19,414 | $1.0M | $385,226 |
| 2020 | 33 | 2,149 | 17,399 | $817,252 | $325,521 |
Total Patients
8,027
Total Services
66,689
Medicare Billing
$1.3M
Procedure Codes
116
All Medicare Procedures & Services
116 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 12 | 5,100 | $127,500 | $87,828 | 68.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 392 | 510 | $71,400 | $43,297 | 60.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 163 | 165 | $134,475 | $30,654 | 22.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 214 | 214 | $39,962 | $23,656 | 59.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 97 | 487 | $26,785 | $17,296 | 64.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 97 | 289 | $21,675 | $13,621 | 62.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 212 | 226 | $101,700 | $11,961 | 11.8% |
| 91120 | Test for tone and sensation of rectum and anus | Office | 2023 | 29 | 29 | $17,020 | $10,040 | 59.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 94 | 161 | $13,685 | $9,444 | 69.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 90 | 94 | $14,570 | $8,914 | 61.2% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 70 | 76 | $81,800 | $6,975 | 8.5% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2023 | 11 | 12 | $12,360 | $6,252 | 50.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 90 | 91 | $62,335 | $6,047 | 9.7% |
| 91122 | Study of rectum sensitivity and function | Office | 2023 | 29 | 29 | $8,930 | $5,640 | 63.2% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 30 | 30 | $7,380 | $4,614 | 62.5% |
| 74170 | Ct scan of abdomen before and after contrast | Office | 2023 | 32 | 32 | $6,880 | $3,806 | 55.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 25 | 36 | $7,560 | $3,275 | 43.3% |
| 90912 | Biofeedback training for bowel or bladder control, initial 15 minutes | Office | 2023 | 17 | 56 | $4,760 | $3,240 | 68.1% |
| 90913 | Biofeedback training for bowel or bladder control, each additional 15 minutes | Office | 2023 | 17 | 112 | $3,920 | $2,669 | 68.1% |
| 76705 | Limited ultrasound scan of abdomen | Office | 2023 | 42 | 44 | $2,958 | $1,566 | 52.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 13 | 14 | $8,120 | $1,552 | 19.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 24 | $2,400 | $1,393 | 58.0% |
| 78268 | Nuclear medicine study to assess exhaled breath samples | Office | 2023 | 11 | 13 | $2,145 | $1,203 | 56.1% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 11 | 11 | $1,430 | $839.52 | 58.7% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 65 | 6,500 | $3,250 | $724.97 | 22.3% |
About Dr. Scott Sarrels, M.D
Dr. Scott Sarrels, M.D is a Gastroenterology healthcare provider based in Dothan, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2010. The National Provider Identifier (NPI) number assigned to this provider is 1588981872.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Sarrels, M.D has received a total of $15,718 in payments from pharmaceutical and medical device companies, with $1,306 received in 2024. These payments were reported across 546 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($10,353).
As a Medicare-enrolled provider, Sarrels has provided services to 8,027 Medicare beneficiaries, totaling 66,689 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 116 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Student in an Organized Health Care Education/Training Program, Internal Medicine
- Location Dothan, AL
- Active Since 04/26/2010
- Last Updated 10/11/2016
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1588981872
Products in Payments
- XIFAXAN (Drug) $5,616
- STELARA (Biological) $1,245
- RINVOQ (Biological) $577.82
- TRULANCE (Drug) $564.72
- SKYRIZI (Biological) $509.12
- ZEPOSIA (Drug) $469.92
- ENTYVIO (Biological) $462.78
- LINZESS (Drug) $396.17
- Alinia Tablets 500mg 30 count bottle (Drug) $373.47
- HUMIRA (Biological) $344.71
- DUPIXENT (Biological) $311.25
- XELJANZ (Drug) $306.98
- Humira (Biological) $293.68
- Trulance (Drug) $247.25
- Linzess (Drug) $242.17
- OCALIVA (Drug) $230.92
- CREON (Drug) $213.01
- GATTEX (Drug) $150.07
- Barrx (Device) $147.22
- INTERSTIM (Device) $133.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Dothan
Mr. Travis Rutland, Md, MD
Gastroenterology — Payments: $265,022
Gastroenterology $265,022
Dr. Paul Lamb, Md, MD
Gastroenterology — Payments: $111,968
Gastroenterology $111,968
Samuel Tarwater, Md, MD
Gastroenterology — Payments: $15,397
Gastroenterology $15,397
William Mclaughlin, Md, MD
Gastroenterology — Payments: $9,913
Gastroenterology $9,913
George Nelson, M.d, M.D
Gastroenterology — Payments: $8,417
Gastroenterology $8,417
Jeffrey Crittenden, Md, MD
Gastroenterology — Payments: $8,300
Gastroenterology $8,300